Kevin Rakin - 11 Feb 2022 Form 4/A - Amendment Insider Report for ORAMED PHARMACEUTICALS INC. (ORMP)

Role
Director
Signature
/s/ Kevin Rakin
Issuer symbol
ORMP
Transactions as of
11 Feb 2022
Net transactions value
$0
Form type
4/A - Amendment
Filing time
15 Feb 2022, 16:30:20 UTC
Date Of Original Report
14 Feb 2022
Previous filing
05 Jan 2022
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORMP Common Stock Gift $0 -5,000 -8.6% $0.000000 53,004 11 Feb 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.
F2 This amendment is being filed to correct an administrative error in the Form 4 filed by Mr. Rakin, which reported that 47,004 shares of common stock are beneficially owned by him following the reported transaction. Mr. Rakin beneficially owned 53,004 shares of common stock following the reported transaction.